(Total Views: 445)
Posted On: 04/19/2021 5:09:29 PM
Post# of 155808

Re: reallypeople? #87169
Reduction in CTCs could not be a primary endpoint. The FDA wants to see results that are a beneficial clinical result to the patient.

